68 related articles for article (PubMed ID: 2263025)
1. [Steroid withdrawal in renal transplant recipients].
Nakamura H; Murai M; Asano T; Takao M; Yoshizawa N; Sekiguchi S
Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1033-7. PubMed ID: 2263025
[TBL] [Abstract][Full Text] [Related]
2. Steroid withdrawal in kidney transplant recipients: is it a safe option?
Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
[TBL] [Abstract][Full Text] [Related]
3. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
4. Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation.
van de Wetering J; Gerrits JH; van Besouw NM; Ijzermans JN; Weimar W
Transplantation; 2009 Mar; 87(5):740-4. PubMed ID: 19295320
[TBL] [Abstract][Full Text] [Related]
5. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
[TBL] [Abstract][Full Text] [Related]
6. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
Roberti I; Reisman L; Lieberman KV; Burrows L
Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
8. Withdrawal of steroid immunosuppression in renal transplant recipients.
Stratta RJ; Armbrust MJ; Oh CS; Pirsch JD; Kalayoglu M; Sollinger HW; Belzer FO
Transplantation; 1988 Feb; 45(2):323-8. PubMed ID: 3278423
[TBL] [Abstract][Full Text] [Related]
9. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data.
Hamiwka LA; Burns A; Bell L
Pediatr Transplant; 2006 May; 10(3):337-44. PubMed ID: 16677358
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
[TBL] [Abstract][Full Text] [Related]
11. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.
Keogh A; Macdonald P; Harvison A; Richens D; Mundy J; Spratt P
J Heart Lung Transplant; 1992; 11(2 Pt 2):421-7. PubMed ID: 1571340
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of enteric-coated mycophenolate sodium in de novo and maintenance renal transplant patients.
Nart A; Sipahi S; Aykas A; Uslu A; Hoşcoşkun C; Toz H
Transplant Proc; 2008; 40(1):189-92. PubMed ID: 18261583
[TBL] [Abstract][Full Text] [Related]
13. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
[TBL] [Abstract][Full Text] [Related]
14. Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity.
Klaus G; Jeck N; Konrad M; Förster B; Soergel M
Clin Nephrol; 2001 Dec; 56(6):S37-42. PubMed ID: 11770812
[TBL] [Abstract][Full Text] [Related]
15. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
16. Successful steroid withdrawal after long-term administration in renal transplant patients.
Amada N; Kikuchi H; Haga I; Fukumori T; Sato A; Sato T
Transplant Proc; 2009; 41(1):135-7. PubMed ID: 19249498
[TBL] [Abstract][Full Text] [Related]
17. Successful withdrawal of corticosteroids in heart transplantation.
Miller LW; Wolford T; McBride LR; Peigh P; Pennington DG
J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
19. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients.
Hricik DE; Seliga RM; Fleming-Brooks S; Bartucci MR; Schulak JA
Clin Transplant; 1995 Oct; 9(5):419-23. PubMed ID: 8541637
[TBL] [Abstract][Full Text] [Related]
20. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]